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Summary
Physical separation between the mammalian immune system and commensal bacteria is necessary 
to limit chronic inflammation. However, selective species of commensal bacteria can reside within 
intestinal-associated lymphoid tissues of healthy mammals. Here, we demonstrate that lymphoid 
tissue-resident commensal bacteria (LRC) colonized murine dendritic cells and modulate their 
cytokine production. In germ-free and antibiotic-treated mice, LRCs colonized intestinal-
associated lymphoid tissues and induced multiple members of the IL-10 cytokine family, including 
dendritic cell-derived IL-10 and group 3 innate lymphoid cell (ILC3)-derived IL-22. Notably, 
IL-10 limited the development of pro-inflammatory Th17 cell responses, and IL-22 production 
enhanced LRC colonization in the steady state. Furthermore, LRC colonization protected mice 
from lethal intestinal damage in an IL-10-IL-10R-dependent manner. Collectively, our data reveal 
a unique host-commensal bacteria dialogue whereby selective subsets of commensal bacteria 
interact with dendritic cells to facilitate tissue-specific responses that are mutually beneficial for 
both the host and the microbe.
Graphical abstract
Introduction
Trillions of microorganisms constitutively colonize the mammalian gastrointestinal (GI) 
tract and are essential to aid in nutrient metabolism and resistance to pathogen infection, as 
well as the development and maturation of the immune system (Belkaid and Hand, 2014; 
Honda and Littman, 2012; Hooper et al., 2012). In the healthy intestine, most commensal 
bacteria are restricted to the lumen of the GI tract or found associated with the surface of the 
intestinal epithelium and remain physically separated from the immune cells that populate 
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the lamina propria and intestinal-associated lymphoid tissues including isolated lymphoid 
follicles (ILF), Peyer’s patches (PP) and the mesenteric lymph nodes (mLN) (Chow et al., 
2010; Hooper et al., 2012; Hooper and Macpherson, 2010). Physical separation of 
commensal bacteria from immune cells is achieved by multiple physical and biochemical 
mechanisms that include epithelial cells that line the intestine, tight junction proteins, and 
secretion of anti-microbial peptides, mucus and immunoglobulin A (Chow et al., 2010; 
Hooper et al., 2012; Hooper and Macpherson, 2010). Anatomical segregation of commensal 
bacteria from the immune system, often referred to as the “demilitarized zone”, is essential 
to prevent pathologic immune responses against commensal bacteria (Hooper et al., 2012; 
Hooper and Macpherson, 2010). Consistent with this, translocation of commensal bacteria 
across the intestinal epithelium can lead to the generation of pro-inflammatory immune cell 
responses and are often associated with the pathogenesis of multiple chronic diseases, such 
as inflammatory bowel disease, metabolic disorders and HIV/AIDS (Brenchley and Douek, 
2012; Manichanh et al., 2012).
Recent studies suggest that a unique subset of commensal bacteria can colonize the interior 
of intestinal-associated lymphoid tissues of healthy mammals (Fung et al., 2014; Kunisawa 
and Kiyono, 2012; Obata et al., 2010; Sonnenberg et al., 2012). Using 16S rDNA 
sequencing and fluorescence in situ hybridization (FISH), one report identified the presence 
of multiple species of commensal bacteria in the interior of ILFs, PPs and the mLN of 
healthy mice, non-human primates and humans (Obata et al., 2010). These bacteria include 
Alcaligenes spp., Achromobacter spp., Bordetella spp. and Ochrobactrum spp. 16S rDNA 
for many of these lymphoid tissue-resident commensal bacteria (LRCs) were found 
associated with CD11c+ dendritic cells (DCs), suggesting a role for DCs in lymphoid tissue 
colonization. In a subsequent study, it was demonstrated that interleukin (IL)-22 and group 3 
innate lymphoid cells (ILC3) are important in preventing systemic dissemination of one 
LRC, Alcaligenes xylosoxidans, and subsequent induction of systemic inflammation 
(Sonnenberg et al., 2012). These data highlight that intestinal-associated lymphoid tissues 
are potential sites for colonization by commensal bacteria and innate immune pathways 
maintain anatomical containment between LRCs and the systemic immune system. Despite 
these findings, the mechanisms by which commensal bacteria colonize immune cell-rich 
lymphoid compartments associated with the intestine of healthy mammals, and the 
functional significance of this colonization to the host remain undefined.
In this report, we demonstrate that LRCs can colonize murine DCs, modulate DC cytokine 
production in a viability-dependent manner and promote local Th17 cell and ILC3 responses 
in intestinal-associated lymphoid tissues in vivo. Further, our data indicate that ILC3-derived 
IL-22 enhanced LRC colonization of intestinal-associated lymphoid tissues, and LRC-
induced IL-10 limited pro-inflammatory responses in the steady state and could protect mice 
in a model of intestinal damage. Collectively, these data demonstrate that LRCs engage in a 
mutualistic dialogue with mammalian hosts by eliciting members of the IL-10 cytokine 
family.
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Results
Lymphoid tissue-resident commensal bacteria colonize murine dendritic cells
16S rDNA for several groups of bacteria have been detected in the interior of PPs and the 
mLN of healthy mice (Obata et al., 2010; Sonnenberg et al., 2012). These LRCs, including 
Achromobacter spp., Alcaligenes spp., Bordetella spp. and Ochrobactrum spp., belong 
exclusively to the α- and β-proteobacteria groups, which are not highly represented in 
sequence analyses of the luminal contents of the intestine (Belkaid and Hand, 2014; Honda 
and Littman, 2012; Hooper et al., 2012). We constructed a phylogenetic tree using in-house 
sequenced and publically available reference genomes of α-, β-, γ-proteobacteria and 
Bacteroidia members (Table S1). Phylogenetic analyses indicated that members of the α-
proteobacteria and β-proteobacteria LRCs form two distinct clades from γ-proteobacteria 
and Bacteroidia members, which are typically found in the lumen of the intestine and not 
associated with intestinal lymphoid tissues in healthy mammals (Figure 1A).
16S rDNA for LRCs have been detected in CD11c+ cells from PPs and the mLN of healthy 
mice (Obata et al., 2010), suggesting LRCs may colonize DCs. To test this, bone marrow-
derived DCs (BMDCs) were co-cultured with bacteria predicted to be LRCs or 
representative intestinal microbes not predicted to be LRCs (non-LRCs), and the ability of 
each bacterium to survive in DCs was determined using a gentamicin protection assay. LRCs 
and non-LRCs were both internalized by DCs, but the numbers of viable non-LRCs declined 
rapidly within the first 3 days of culture, while viable LRCs persisted at high levels on days 
2 and 4 (Figure 1B). LRCs but not non-LRCs were also able to colonize primary DCs 
isolated from the mLN and spleen (Figure 1C and S1A). Transmission electron microscopy 
demonstrated intracellular colonization of DCs by LRCs as noted by the presence of dense 
bacterial clusters within intracellular vesicles (Figure 1D), and an immunofluorescence 
assay confirmed the presence of intracellular live LRCs on days 2 and 5 post colonization 
(Figure 1E–F). Together, these data suggest that, in contrast to luminal-resident commensal 
bacteria, LRCs have the ability to efficiently colonize and persist in murine DCs.
Lymphoid tissue-resident commensal bacteria modulate dendritic cell cytokine production 
in a viability-dependent manner
Based on the ability of LRCs to colonize and persist in murine DCs, we sought to 
characterize DC cytokine induction following exposure to live versus heat-killed LRCs. To 
investigate this, genome-wide transcriptional profiling was performed on DCs treated with 
PBS, live or heat-killed Bordetella spp., a model LRC isolated from our mouse colony, at 4 
days post-colonization. Analysis of canonical DC-derived cytokines revealed that DCs 
colonized with live LRCs expressed greater levels of both pro- and anti-inflammatory 
cytokines Il6, Il23a, Il18, Il12a, Il12b, Il10 and Tgfb2 as compared with PBS-treated DCs 
(Figure 2A). Notably, the induction of mRNA and protein for several of these cytokines, 
including IL-1β, IL-6, IL-10, IL-12p40 and IL-23, by live LRCs was detected as early as 24 
hours post co-culture (Figure 2B and 2C), and the induction of IL-10 and IL-23 mRNA 
(Figure 2A and 2B) and was diminished in DCs exposed to only heat-killed LRCs, 
suggesting that viability-dependent factors expressed by LRCs induce selective DC cytokine 
responses. Primary splenic DCs exposed to live LRCs also produced IL-1β, IL-6, IL-10 and 
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IL-12p40 (Figure S1B). Efficient induction of both viability- (IL-1β, IL-10, IL-23) and non-
viability-dependent cytokines (IL-6, IL-12p40) required MYD88, suggesting a role for Toll-
like receptors (TLRs) in recognition of LRCs (Figure S2A). Consistent with this, production 
of IL-1β and IL-23 was significantly reduced in Tlr4−/− but not Tlr2−/− BMDCs (Figure 
S2B). Collectively, these data indicate that LRC colonization of DCs induces distinct pro- 
and anti-inflammatory cytokine responses in a viability- and TLR-dependent manner.
Lymphoid tissue-resident commensal bacteria promote tissue-specific Th17 cell 
responses
To test whether these LRCs can stably colonize and survive in intestinal-associated 
lymphoid tissues, germ-free (GF) mice were monocolonized with Bordetella spp., a model 
LRC isolated from our mouse colony. At day 10 post-inoculation, viable LRCs were 
consistently detected in the mLN (Figure 3A), PPs (Figure 3B) and fecal contents of the 
intestinal lumen (Figure 3C), but not the spleen and liver. However, colonization by LRCs 
was not associated with macroscopic or microscopic inflammation in the intestine at 2 
weeks post colonization (Figure S3A). These data support the hypothesis that LRCs can 
colonize and persist in intestinal-associated lymphoid tissues of healthy mammals.
Based on the ability of live LRCs to elicit IL-1β, IL-6, IL-23 and TGFβ, we hypothesized 
that LRCs may promote Th17 cell responses in colonized lymphoid tissues. To test this, we 
analyzed CD4+ T cells in the PP, mLN and small intestine lamina propria (SI LP) of 
conventionally-housed (CNV), GF, LRC-monocolonized mice, as well as mice 
monocolonized with segmented filamentous bacteria (SFB), an epithelial-associated 
commensal bacterium which has previously been shown to induce robust Th17 cell 
responses (Gaboriau-Routhiau et al., 2009; Ivanov et al., 2009). Consistent with published 
reports, GF mice lacked Th17 cells in the mLN (Figure 3D), PP (Figure 3E) and SI LP 
(Figure 3F) compared to CNV mice, and SFB was sufficient to promote robust Th17 cell 
responses in these tissues. In contrast, LRCs promoted Th17 cell responses in the mLN and 
PP (Figure 3D, 3E and 3G) but failed to promote Th17 cell responses in the SI LP, 
suggesting tissue-specific modulation of the immune system (Figure 3F–G). Analysis of 
LRC-elicited Th17 cells in the PP revealed co-expression of the IL-10 family cytokine, 
IL-22 (Figure 3H and 3I). Accumulation of Th17 cells was selective, as LRCs did not 
significantly promote IFNγ-producing Th1 cell responses in the mLN, PP or SI LP (Figure 
S3B). Although significant Th17 cell responses were observed in the PP and mLN of LRC-
monocolonized mice, the magnitude of these responses was lower than that observed in 
SFB-monocolonized mice (Figure 3D–F), suggesting that LRCs are less efficient at inducing 
Th17 cell responses or are actively supressing Th17 cell responses. Since LRCs could 
promote IL-10 by DCs in vitro (Figures 2A–C and S1B) and IL-10 has been shown to 
suppress Th17 cell responses (Liu et al., 2011; McGeachy et al., 2007; Ouyang et al., 2011), 
we hypothesized that IL-10 may restrain LRC-induced Th17 cells. Consistent with this 
hypothesis, Th17 cells were significantly increased in the mLN (Figure 3J and 3K) and PP 
(Figure S3C and S3D) of LRC-monocolonized Il10−/− mice compared to LRC-
monocolonized Il10+/+ mice. Thus, LRCs selectively promote local Th17 cell responses in 
intestinal-associated lymphoid tissues, and the magnitude of these responses is limited by 
co-induction of IL-10.
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Lymphoid tissue-resident commensal bacteria promote tissue-specific ILC3 responses
Based on the ability of live LRCs to elicit DC-derived IL-1β, IL-6 and IL-23, we 
hypothesized that LRCs may also promote ILC3 responses in intestinal-associated lymphoid 
tissues. To test this, we measured ILC3 frequencies in the PP, mLN and SI LP of CNV, GF, 
SFB-monocolonized and LRC-monocolonized mice. Consistent with published reports, GF 
mice have reduced frequencies of ILC3 in the SI LP as compared to CNV mice (Klose et al., 
2013; Satoh-Takayama et al., 2008). Monocolonization by SFB did not significantly alter 
ILC3 frequencies in the PP, mLN and SI LP as compared to GF mice (Figure 4A–D). In 
contrast, LRC-monocolonized mice revealed a significant increase in ILC3 frequencies in 
the PP and mLN (Figure 4A, 4B and 4D) but not in the SI LP as compared to GF mice 
(Figure 4C and 4D). However, total numbers of ILC3s in the mLN did not change following 
LRC monocolonization (Figure S3E). Notably, ILC3s in the PP of LRC-monocolonized 
mice produced IL-22 (Figure 4E). Thus, LRCs modulate tissue-specific Th17 cell and ILC3 
responses in healthy mammalian lymphoid tissues.
Lymphoid tissue-resident commensal bacteria promote ILC3-derived IL-22 responses that 
enhance tissue colonization
ILC3 and IL-22 responses induce anti-microbial proteins in the intestine (Sonnenberg et al., 
2011; Sonnenberg and Artis, 2015), suggesting that LRCs may induce immune responses 
that limit its own colonization or the colonization of other bacteria. To test these 
possibilities, we established a mouse model of LRC colonization by treating conventional 
C57BL/6 mice with a limited cocktail of antibiotics (ABX) followed by inoculation with an 
antibiotic-resistant LRC, Achromobacter (LRCR). We confirmed that, similar to our results 
using LRC-monocolonized mice, LRCR could be cultured from the mLN, PPs and intestinal 
lumen of LRCR-colonized C57BL/6 mice (Figure 5A–B). Furthermore, analyses of ILC3 
responses in LRCR-colonized C57BL/6 mice revealed a significant increase in IL-22+ ILC3 
frequencies as compared to ABX-treated controls (Figure S4A). Live LRCR were also 
detected in the mLN of LRCR-colonized Rag1−/− mice (Figure 5C), allowing us to 
interrogate selective interactions between LRCs and the innate immune system. To 
investigate whether DC colonization and cytokine modulation by LRCs also occur in the 
absence an adaptive immune system in vivo, we measured LRCR 16S rDNA and cytokine 
gene expression in CD11c+ cells isolated from the mLN of LRCR-colonized Rag1−/− mice. 
LRCR 16S rDNA was detected in CD11c+ cells from LRCR-colonized but not in control 
ABX-treated mice (Figure 5D). Furthermore, CD11c+ cells from LRCR-colonized mice 
expressed increased levels of Il1b, Il10 and Il23a as compared to CD11c+ cells from control 
ABX-treated mice (Figure 5E). Induction of Il1b and Il23a was associated with an increase 
in Il17a and Il22 expression in the whole mLN but not the small intestine of LRCR-
colonized Rag1−/− mice (Figure 5F and S4B).
Multiple reports suggest that IL-17A and IL-22 limit intestinal colonization of the 
commensal bacterium SFB (Qiu et al., 2013; Shih et al., 2014; Upadhyay et al., 2012). 
Therefore, we hypothesized that induction of IL-17A and IL-22 by LRCs would be 
important in limiting its own colonization in intestinal-associated lymphoid tissues. To test 
this, ABX-treated C57BL/6, Il17a−/− and Il22−/− mice were inoculated with LRCR and 
lymphoid tissue colonization was assessed 10 days later. Based on the requirement for IL-22 
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in restricting Alcaligenes dissemination (Sonnenberg et al., 2012), we also predicted that 
colonization of Il22−/− mice with LRCR would result in systemic dissemination of LRCR. 
However, systemic dissemination of LRCR was not observed in the absence of either IL-17A 
or IL-22 (Figure S4C). Furthermore, analysis of intestinal-associated lymphoid tissues 
revealed an impaired ability of LRCR to colonize the mLN and PPs of Il22−/− but not 
C57BL/6 or Il17a−/− mice (Figure 5G and 5H). These data suggest that IL-22 may also 
facilitate colonization of lymphoid tissues by commensal bacteria. To test whether innate 
cell-derived IL-22 could impact lymphoid tissue colonization by commensal bacteria, we 
inoculated ABX-treated Rag1−/− and Rag1−/−Il22−/− mice with LRCR and measured 
lymphoid tissue colonization. Similar to our findings using lymphocyte-sufficient Il22−/− 
mice, inoculation of Rag1−/−Il22−/− mice with LRCR did not result in systemic 
dissemination of LRCR (Figure S4D), but resulted in impaired LRCR colonization in the 
mLN (Figure 5I). Collectively, these results suggest that induction of ILC3-derived IL-22 is 
important to facilitate LRC colonization of lymphoid tissues.
The IL-22 receptor is restricted to non-hematopoietic cells and IL-22-IL-22R signaling 
regulates antimicrobial responses in the intestinal lumen and the composition of the 
microbiota (Sonnenberg et al., 2011). Therefore, rather than a direct effect on DCs, we 
hypothesized that in the absence of IL-22 there may be an expansion of commensal bacteria 
that outcompete and limit LRC entry and colonization. To investigate this hypothesis, we 
examined luminal colonization in C57BL/6, Il22−/−, Il17a−/−, Rag1−/− and Rag1−/−Il22−/− 
mice that were treated with a limited ABX cocktail followed by LRCR inoculation. At 10 
days post-inoculation, we detected an absence of fecal LRCR in Il22−/− and Rag1−/−Il22−/− 
but not in C57BL/6, Rag1−/− and Il17a−/− mice (Figure S4E–F). Il22+/+ littermates raised 
under the same conditions as Il22−/− mice also had impaired ABX-mediated fecal LRC 
colonization, and administration of additional antibiotics including neomycin, metronidazole 
and vancomycin, restored fecal LRC colonization in Il22−/− mice and Il22+/+ littermates 
(Figure S4G). Furthermore, cohousing Il22−/− mice with C57BL/6 mice impaired fecal and 
lymphoid tissue LRC colonization in C57BL/6 mice (Figure S4H). Altogether, our data 
indicate that IL-22 promotes LRC colonization by limiting competition with other 
commensal microbes.
To further interrogate the role of IL-22 in regulating LRC colonization, we pursued a gain-
of-function approach. Consistent with a role for IL-22 in promoting lymphoid tissue 
colonization by LRCs, exogenous administration of recombinant mouse IL-22 to LRCR-
colonized Rag1−/− mice significantly enhanced LRCR levels in the mLN (Figure 5J). The 
LRCR colonization model requires the use of antibiotics that can eliminates other 
commensal bacteria. To test the requirement for IL-22 in LRC colonization in the presence 
of a complex microbiota, we measured levels of the endogenous LRC, Alcaligenes by FISH 
in conventional Il22−/− mice and littermate controls. Compared to Il22+/+ littermates, 
conventional Il22−/− mice have reduced Alcaligenes puncta in the PP and mLN (Figure 5K 
and 5L). These data demonstrate that IL-22 plays a critical role in enhancing the 
colonization of intestinal-associated lymphoid tissues by LRCs in the presence of a complex 
microbiota.
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Lymphoid tissue-resident commensal bacteria colonization provides protection from 
chemical-induced inflammation and intestinal injury in an IL-10-dependent manner
To test whether there was a benefit to mammalian hosts following LRC colonization, we 
employed a model of intestinal damage where administration of the chemical, dextran 
sodium sulfate (DSS), induces significant damage to the colonic epithelium. Compared to 
CNV mice, mice lacking commensal bacteria or treated orally with a broad-spectrum 
cocktail of antibiotics are highly sensitive to intestinal damage induced by DSS and 
succumb to disease (Ayres et al., 2012; Kitajima et al., 2001; Maslowski et al., 2009). To test 
the functional significance of LRC colonization following DSS treatment, we administered 
2% DSS to CNV, ABX-treated alone and LRCR-colonized Rag1−/− mice for 6–7 days, then 
removed DSS, and re-administered normal drinking water. Compared to CNV mice, which 
survived throughout the duration of the experiment (21 days), ABX-treated mice exhibited 
significant systemic and intestinal morbidity and succumbed to disease by day 10 post DSS 
administration (Figure 6A, Figure S5A). In contrast, LRCR-colonized mice were largely 
protected from DSS-induced mortality, and demonstrated significantly reduced weight loss 
and elevated red blood cell counts as compared to ABX-treated controls (Figure 6A–B, 
S5A–B). Further, analyses on day 5 post DSS administration revealed that although CNV 
mice did not exhibit significant intestinal damage or inflammation in the colon at this low 
dose of DSS, the colons of ABX-treated mice displayed severe loss of crypt architecture and 
extensive inflammation (Figure 6C). In contrast, LRCR-colonized mice had visible but 
reduced intestinal tissue damage and inflammation (Figure 6C). LRC-conferred protection 
from DSS-induced mortality was also observed in gnotobiotic C57BL/6 (Figure S5C) and 
Rag1−/− (Figure S5D) mice monocolonized with Bordetella spp., suggesting that host 
protection can occur in the absence of other commensal bacteria. Collectively, our data 
demonstrate that colonization of lymphoid tissues by selective commensal bacteria is host 
beneficial in the context of intestinal damage and inflammation.
To investigate whether LRC-induced IL-22 is providing host protection in LRCR-colonized 
mice, we administered anti-IL-22 neutralizing antibody to LRCR-colonized Rag1−/− mice 
during exposure to DSS. Anti-IL-22-treated mice exhibited comparable weight loss to IgG-
treated mice (Figure S6B), suggesting that IL-22 is not involved in LRC-mediated host 
protection from DSS. As the anti-inflammatory cytokine IL-10 was also induced upon LRC 
colonization both in the steady state and during DSS exposure (Figure 2 and Figure S6A), 
we interrogated whether innate cell-derived IL-10 is providing host protection in LRCR-
colonized mice. To test this, we administered anti-IL-10R neutralizing antibody to LRCR-
colonized Rag1−/− mice during exposure to DSS. Blockade of IL-10-IL-10R interactions 
resulted in increased weight loss and colonic inflammation as compared to IgG-treated 
controls (Figure 6D, S6C–D). ABX-treated Rag1−/− mice on DSS display elevated levels of 
serum IFNγ, which was significantly diminished in LRCR-colonized Rag1−/− mice (Figure 
6E). Conversely, IL-10R neutralization in LRCR-colonized mice partially restored serum 
IFNγ levels observed in ABX-treated mice (Figure 6E). Treatment of ABX-control Rag1−/− 
animals with anti-IL-10R during DSS exposure did not result in further weight loss or colon 
pathology compared to isotype-treated animals (Figure S6E-F). Collectively, these data 
suggest that LRC colonization protects mice from intestinal and systemic inflammatory 
responses through induction of innate cell-derived IL-10.
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Discussion
Our results define a unique host-commensal bacteria dialogue whereby direct interactions 
between LRCs and the mammalian immune system orchestrate tissue-specific immune 
responses that are mutually beneficial for the host and microbe. While most studies of host-
microbiota interactions to date have focused on populations of commensal bacteria residing 
in the intestinal lumen or attached to the intestinal epithelium, here we interrogate an under-
appreciated class of commensal bacteria that has the potential to reside closely associated 
with immune cells in the interior of intestine-associated lymphoid tissues. This colonization 
pattern is paradoxical to our current understanding of interactions between the immune 
system and the majority of other commensal bacteria, which suggests that anatomical 
segregation must occur to limit the development of pathologic immune responses (Brenchley 
and Douek, 2012; Hooper et al., 2012; Hooper and Macpherson, 2010; Manichanh et al., 
2012). Our data highlighting this unique colonization pattern and selective interactions with 
the healthy mammalian immune system represent a key advance in our understanding of 
host-commensal bacteria relationships.
Interrogating functional interactions between the host immune system and several species of 
LRCs revealed that LRCs but not luminal members of the microbiota could colonize and 
persist within murine DCs and modulate selective DC cytokine responses in a viability-
dependent manner, as has previously been shown for IL-1β (Sander et al., 2011). 
Constitutive colonization of DCs by LRCs likely maintains expression of viability-
dependent cytokines, including IL-1β, IL-10 and IL-23. This is in direct contrast to luminal-
resident or epithelial-attached commensal bacteria in which viable bacteria belonging to 
these groups are not typically found beyond the intestinal epithelium (Hooper et al., 2012; 
Hooper and Macpherson, 2010; Obata et al., 2010). Therefore, these commensal bacteria 
predominantly influence immune cells through indirect interactions, such as via production 
of metabolites or modulation of intestinal epithelial cell responses (Arpaia et al., 2013; 
Furusawa et al., 2013; Ivanov et al., 2009; Smith et al., 2013). Furthermore, our data suggest 
that induction of tissue-specific immune responses by commensal bacteria is linked to their 
anatomical localization in the GI tract and associated lymphoid tissues. Consistent with this, 
SFB, which adheres to the surface of the terminal ileum in mice, induces potent Th17 cell 
responses in the underlying SI LP (Gaboriau-Routhiau et al., 2009; Ivanov et al., 2009). 
Similarly, Bacteroides fragilis predominantly colonizes the colonic crypts in mice and 
promotes robust regulatory T cell responses in the underlying colon lamina propria (Lee et 
al., 2013; Round and Mazmanian, 2010). In our current study, we demonstrate that LRCs 
colonize and activate DCs to selectively promote Th17 and ILC3 responses within intestinal-
associated lymphoid tissues.
Multiple reports suggest that induction of the ILC3-IL-22 pathway limits host colonization 
by pathogenic attaching and effacing bacterial pathogens such as Citrobacter rodentium or 
the commensal bacterium SFB (Qiu et al., 2013; Shih et al., 2014; Sonnenberg et al., 2011; 
Upadhyay et al., 2012). In contrast, our data demonstrate that IL-22 facilitates colonization 
of lymphoid tissues by LRCs. We demonstrate that Il22−/− mice harbor intestinal microbes 
that limit LRC colonization in the lumen likely through competition for space or nutrients. 
This is consistent with IL-22-induced antimicrobial functions on gram-positive commensal 
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bacteria (Hooper and Macpherson, 2010; Sonnenberg et al., 2011). These data collectively 
suggest that IL-22 indirectly promotes LRC colonization in multiple contexts by restricting 
colonization of competing intestinal microbes. We previously reported that ILC3-derived 
IL-22 is a critical pathway that maintains anatomical containment of LRCs in intestinal-
associated lymphoid tissues in healthy mice and that transient loss of this pathway results in 
dissemination of Alcaligenes to systemic lymphoid tissues (Sonnenberg et al., 2012). In the 
current study, we did not observe systemic dissemination of a distinct but related LRC, but 
rather impaired lymphoid tissue entry and colonization in mice deficient in IL-22. Therefore, 
our findings highlight a multifaceted role for IL-22 in maintaining anatomical localization of 
LRCs, by both promoting lymphoid tissue colonization and limiting systemic dissemination.
LRC colonization is sufficient to protect mice from lethal intestinal damage, supporting the 
hypothesis that host recognition of commensal bacteria provides beneficial microbial 
stimulation to limit intestinal damage. It was previously demonstrated that mice lacking the 
pattern recognition receptors TLR2, TLR4 or the downstream adaptor molecule MYD88 are 
also susceptible to lethal DSS-induced intestinal damage (Rakoff-Nahoum et al., 2004), 
suggesting that direct recognition of microbial signals is critical for maintenance of the 
intestinal barrier. Despite our understanding of microbial recognition pathways in host 
protection from intestinal injury, the downstream signals induced are not fully understood. 
Our current data suggest that MYD88-dependent IL-10 induction by LRCs is one pathway 
that provides tissue protective functions in the context of intestinal injury and systemic 
inflammation. These data are consistent with the anti-inflammatory and tissue protective 
roles of IL-10 in the intestine (Kuhn et al., 1993; Ouyang et al., 2011) and that IL-10 
responses in the intestine are dramatically driven by the microbiota (Atarashi et al., 2011; 
Chiu and Ching, 2014; Geuking et al., 2011; Ueda et al., 2010). Our data support a model 
whereby, following LRC colonization, IL-10 produced by DCs in intestinal-associated 
lymphoid tissues has local effects in limiting Th17 cell responses in the steady state, as well 
as distal effects on the intestinal epithelium and systemic circulation in the context of 
intestinal damage.
Collectively, these findings demonstrate a previously unrecognized and mutually beneficial 
dialogue between the host and LRCs. Colonization of lymphoid tissues by commensal 
bacteria modulates the host immune system in a tissue-specific manner and confers 
protective effects in the context of intestinal damage. From an evolutionary perspective, 
there may be multiple beneficial functions for permitting colonization of mammalian 
lymphoid tissues by selective commensal bacteria. However, it is likely that a tightly 
regulated balance between beneficial, opportunistic and pathologic bacteria colonization 
must be maintained in the lymphoid tissues in order to prevent chronic inflammation. 
Further interrogation of the role and regulation of LRC colonization in health and disease 
will be critical to understand the complex microbial contexts where LRCs will influence 
tissue immunity and inflammation, and may reveal novel therapeutic targets for the 
treatment of multiple chronic inflammatory diseases.
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Experimental Procedures
Mice
C57BL/6 and Rag1−/− mice were purchased from Jackson Laboratories and used at 6–12 
weeks of age. Conventional mice used as controls in gnotobiotic mice experiments were 
purchased from Jackson Laboratories and co-housed with mice bred in our conventional 
animal facility for at least 7 days before use. C57BL/6 and Rag1−/− mice used as controls for 
knockout mice were either bred in the same animal facility as the knockout mice, purchased 
from Jackson Laboratories and co-housed with mice bred in our SPF animal facility for at 
least 7 days or littermates as indicated to normalize for microbiota differences. All 
conventional mice were maintained in specific pathogen-free facilities at Weill Cornell 
Medical College. Germ-free and gnotobiotic C57BL/6 and Rag1−/− mice were maintained 
within sterile vinyl isolators at Weill Cornell Medical College Gnotobiotic Mouse Facility 
and monitored for germ-free or gnotobiotic status by weekly aerobic and anaerobic 
culturing. Germ-free and gnotobiotic Il10+/+ and Il10−/− mice were maintained at the 
National Gnotobiotic Rodent Resource Center (University of North Carolina, Chapel Hill). 
Additional microbiology testing was performed on feces from mice under experimentation 
and at the endpoint of the experiment to confirm germ free or monocolonization status. DSS 
experiments using gnotobiotic mice were performed in a biosafety cabinet, and the 
gnotobiotic status of mice was confirmed by microbiology testing. Germ-free C57BL/6 mice 
were monocolonized with the mouse LRC isolate Bordetella spp., or SFB by oral gavage or 
cohousing with soiled bedding from previously monocolonized mice for at least 10 days. To 
establish LRC colonization in ABX-treated mice, conventional mice were treated in the 
drinking water with a limited ABX cocktail of ampicillin (1 mg/ml, Sigma) and gentamicin 
(1 mg/ml, Gemini Bio-Products) for C57BL/6, Il22−/− and Il17a−/− mice or ampicillin (1 
mg/ml), gentamicin (1 mg/ml) and neomycin (0.25 mg/ml, Sigma) for Rag1−/− and Rag1−/− 
Il22−/− for 3 days and then orally gavaged with the LRC isolate (LRCR). Neomycin (0.25 
mg/ml), metronidazole (0.5 mg/ml, Sigma) and vancomycin (0.25 mg/ml, Chem-Impex 
International) were added to the limited ABX cocktail as indicated. Antibiotic cocktails were 
supplemented with 1 packet of artificial sweetener (Sweet’N Low) per 250 ml. For cytokine 
treatments in vivo, rmIL-22 or PBS control (kindly provided by Pfizer) was injected i.p. at 
25 μg/mouse every 2 days for 1 week and control- or IL-22-Fc (kindly provided by Pfizer) 
was injected i.p. at 50 μg/mouse every 3 days for 1 week. First injections were administered 
1 day prior to LRCR colonization. All mice were used at least 10 days post LRCR 
colonization. All animals used are on a C57BL/6 background with the exception of Il10−/− 
and Il10+/+ germ free mice, which are on a 129S6/SvEv background. All experiments were 
performed according to the guidelines of the Weill Cornell Medical College Institutional 
Animal Care and Use Committee.
Microbiology
The LRC strain, Bordetella spp., used to colonized BMDCs or monocolonize germ-free 
mice was originally isolated from the spleen of an anti-CD90.2 mAb treated conventional 
Rag1−/− mice using a previously defined protocol (Sonnenberg et al., 2012). E. coli (human 
isolate) and Ochrobactrum spp. used to colonize BMDCs and the ABX-resistant (ampicillin, 
gentamicin, neomycin) LRC (LRCR), Achromobacter used to colonize antibiotic-treated 
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mice were human clinical isolates kindly provided by Kaede V. Sullivan (Children’s 
Hospital of Philadelphia). Bacterial identities were determined by genomic sequencing 
(Wellcome Trust Sanger Institute) and confirmed by genus-specific 16S rDNA primers. E. 
coli R9 (ATCC 35328), Enterobacter cloacae (ATCC 13047) and gentamicin-sensitive 
Achromobacter spp. (ATCC 31444) used to colonize BMDCs were purchased from 
American Type Culture Collection. Feces from SFB-monocolonized mice were obtained 
from Dr. Yoshinori Umesaki and Dr. Tatsuichiro Shima (Yakult). All bacterial strains used to 
colonize GF mice and for in vitro DC assays were grown in LB broth and incubated at 250 
RPM, 37°C for 16–20 hours. For enumeration of tissue and fecal CFUs, the spleen, liver, 
feces, mesenteric lymph nodes (mLN) and Peyer’s patches (PP) were isolated, homogenized 
in sterile PBS and plated on Brain Heart Infusion agar supplemented with 5% defibrinated 
horse blood. When culturing LRCR from tissues and feces, BHI blood agar plates were 
supplemented with 25 μg/ml ampicillin.
Bone marrow-derived and primary dendritic cell assays
Bone marrow-derived DCs were generated by culturing bone marrow cells in the presence of 
20 ng/mL GM-CSF for 8–10 days. Culture media was replaced with fresh media every 3 
days. Frequencies of CD11c+ cells were ≥ 95%. To prepare primary splenic and mLN DCs, 
C57BL/6 mice were first injected subcutaneously in the right flank with 5 x 106 cells GM-
CSF-expressing B16 melanoma (kindly provided by Jedd D. Wolchok, MSKCC). 10 days 
later, CD11c+ cells were purified from Liberase TL (Roche)-digested spleen and mLN using 
CD11c positive selection beads (Miltenyi Biotec). Cell purities in the spleen were 
approximately 90% CD11c+ CD11b+ of non-T and B cells. For intracellular bacterial 
survival assays, BMDCs were seeded on 6-well plates at 5 x 106 cells/well in antibiotic-free 
media and co-cultured with bacteria at an MOI of 50 for 2 hours, harvested and washed 3 
times with sterile PBS. BMDCs were then plated in media containing gentamicin (100 
μg/mL) at 200,000 cells/well on 48-well plates and lysed with sterile water every 48 hours to 
enumerate CFUs. For ELISA and qPCR, BMDCs were co-cultured with bacteria at an MOI 
of 50 for 2 hours and then gentamicin-treated to kill extracellular bacteria. Culture 
supernatants and cell lysates were harvested for ELISA and qPCR, respectively, 24 hours 
later. Heat killing was performed by incubating bacterial suspensions at 70°C for 60 mins. 
For transmission electron microscopy, BMDCs colonized with Bordetella spp. for 5 days 
were harvested, processed and imaged using the Jeol-1010 transmission electron 
microscope. For microarray analysis, BMDCs were co-cultured with bacteria for 2 hours, 
washed extensively with PBS, incubated in media containing gentamicin (100 μg/mL) and 
lysed in TRIzol on day 4. All cell incubations were performed at 37°C and 5% CO2.
Immunofluorescent detection of intracellular bacteria
BMDC-bacteria co-cultures were harvested on days 0, 2 and 5 and transferred to glass slides 
via cytospin. BMDCs were fixed with 4% PFA for 30 minutes at room temperature and 
stained with the Live/Dead BacLight Bacterial Viability Kit according to the manufacturer’s 
instructions (Invitrogen). Cells were mounted with VectaShield mounting medium 
containing DAPI (Vector Laboratories) and imaged on the Nikon Eclipse Ti Fluorescence 
Inverted Microscope. PFA fixation did not affect the ability of the bacterial viability kit to 
distinguish between live and dead bacteria.
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Gene expression profiling and quantitative real-time PCR
RNA was isolated using TRIzol reagent (Life Technologies) according to the manufacturer’s 
instructions. cDNA was generated using Superscript reverse transcriptase II (Invitrogen). 
Quantitative real-time PCR was performed using SYBR green chemistry (Invitrogen) and 
QuantiTect Primer Assays (Qiagen) on the ABI 7500 real-time PCR system (Applied 
Biosystems). Samples were normalized to β-actin and displayed as fold change over PBS-
treated BMDCs or antibiotic-treated mice. For microarray analysis, BMDCs colonized with 
the LRC, Bordetella spp., for 4 days were lysed directly in TRIzol. RNA was isolated, 
amplified, reverse-transcribed to cDNA and hybridized to an Affymetrix GeneChip (Mouse 
Gene 1.0ST). Relative expression data was normalized by Z score transformation.
Histological sections
Tissues from the small and large intestines were fixed with 4% PFA, embedded in paraffin, 
and 5 μm sections were cut and stained with H&E.
DSS-induced intestinal damage
Mice were administered 2% DSS (MW 36,000–50,000, MP Biochemicals) in their drinking 
water ad libitum for the number of days indicated and then placed on regular drinking water. 
Disease severity was cumulatively scored based on rectal bleeding (out of 2), fecal 
consistency (out of 2), general appearance (out of 4), weight loss (out of 4) and rectal 
temperature (out of 4). For antibody treatments during DSS, mice were administered i.p. 500 
μg/mouse of rat IgG, anti-IL22-01 (mouse neutralizing antibody developed by Pfizer) or 
anti-IL-10R (clone 1B1.3A, Bio X Cell) 1 day prior to DSS treatment, then on days 2, 5 and 
7. Mice were sacrificed on day 8.
Statistical analyses
Results represent mean ± SEM and statistical analyses were performed by unpaired 
student’s t-test, one- or two-way ANOVA with or without multiple comparisons tests as 
indicated in figure legends.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
We thank members of the Sonnenberg laboratory for discussions and critical reading of the manuscript. This 
research is supported by the National Institutes of Health (DP5OD012116, R56AI114724 and R01AI123368 to 
G.F.S.), and the NIAID Mucosal Immunology Studies Team (MIST) Scholar Award in Mucosal Immunity (to 
G.F.S.), the Crohn’s and Colitis Foundation of America (to M.R.H.), the Cancer Research Institute Student Training 
and Research in Tumor Immunology grant (to T.C.F), the Wellcome Trust (098051) and Medical Research Council 
UK (PF451) for library preparation, sequencing and genomic analysis, the Ministry of Education, Culture, Sports 
and Technology of Japan (Grants-in-Aid for Scientific Research B [J.K.] and for Scientific Research S [H.K.]), the 
Ministry of Health and Welfare of Japan (J.K. and H.K.), Japan Science and Technology Agency (JST), Core 
Research for Evolutional Science and Technology (CREST) (H.K.), P30-DK034987 (R.B.S.) and 5-P40-OD010995 
(R.B.S.). We thank Sylvester S. Roundtree Jr. (Children’s Hospital of Philadelphia) for providing clinical bacterial 
isolates and National Gnotobiotic Rodent Resource Center for providing germ animals.
Fung et al. Page 13
Immunity. Author manuscript; available in PMC 2017 March 15.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
References
Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer 
PJ, Rudensky AY. Metabolites produced by commensal bacteria promote peripheral regulatory T-
cell generation. Nature. 2013; 504:451–455. [PubMed: 24226773] 
Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, Cheng G, Yamasaki S, Saito T, 
Ohba Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 
2011; 331:337–341. [PubMed: 21205640] 
Ayres JS, Trinidad NJ, Vance RE. Lethal inflammasome activation by a multidrug-resistant pathobiont 
upon antibiotic disruption of the microbiota. Nature medicine. 2012; 18:799–806.
Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014; 157:121–141. 
[PubMed: 24679531] 
Brenchley JM, Douek DC. Microbial translocation across the GI tract. Annual review of immunology. 
2012; 30:149–173.
Chiu CC, Ching YH. Monocolonization of germ-free mice with Bacteroides fragilis protects against 
dextran sulfate sodium-induced acute colitis. 2014; 2014:675786.
Chow J, Lee SM, Shen Y, Khosravi A, Mazmanian SK. Host-bacterial symbiosis in health and disease. 
Advances in immunology. 2010; 107:243–274. [PubMed: 21034976] 
Fung TC, Artis D, Sonnenberg GF. Anatomical localization of commensal bacteria in immune cell 
homeostasis and disease. Immunological reviews. 2014; 260:35–49. [PubMed: 24942680] 
Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, 
Kato T, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory 
T cells. Nature. 2013; 504:446–450. [PubMed: 24226770] 
Gaboriau-Routhiau V, Rakotobe S, Lecuyer E, Mulder I, Lan A, Bridonneau C, Rochet V, Pisi A, De 
Paepe M, Brandi G, et al. The key role of segmented filamentous bacteria in the coordinated 
maturation of gut helper T cell responses. Immunity. 2009; 31:677–689. [PubMed: 19833089] 
Geuking MB, Cahenzli J, Lawson MA, Ng DC, Slack E, Hapfelmeier S, McCoy KD, Macpherson AJ. 
Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity. 2011; 
34:794–806. [PubMed: 21596591] 
Honda K, Littman DR. The microbiome in infectious disease and inflammation. Annual review of 
immunology. 2012; 30:759–795.
Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. 
Science. 2012; 336:1268–1273. [PubMed: 22674334] 
Hooper LV, Macpherson AJ. Immune adaptations that maintain homeostasis with the intestinal 
microbiota. Nat Rev Immunol. 2010; 10:159–169. [PubMed: 20182457] 
Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, 
Lynch SV, et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell. 2009; 
139:485–498. [PubMed: 19836068] 
Kitajima S, Morimoto M, Sagara E, Shimizu C, Ikeda Y. Dextran sodium sulfate-induced colitis in 
germ-free IQI/Jic mice. Experimental animals / Japanese Association for Laboratory Animal 
Science. 2001; 50:387–395. [PubMed: 11769541] 
Klose CS, Kiss EA, Schwierzeck V, Ebert K, Hoyler T, d’Hargues Y, Goppert N, Croxford AL, 
Waisman A, Tanriver Y, Diefenbach A. A T-bet gradient controls the fate and function of CCR6-
RORgammat+ innate lymphoid cells. Nature. 2013; 494:261–265. [PubMed: 23334414] 
Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic 
enterocolitis. Cell. 1993; 75:263–274. [PubMed: 8402911] 
Kunisawa J, Kiyono H. Alcaligenes is Commensal Bacteria Habituating in the Gut-Associated 
Lymphoid Tissue for the Regulation of Intestinal IgA Responses. Frontiers in immunology. 2012; 
3:65. [PubMed: 22566946] 
Lee SM, Donaldson GP, Mikulski Z, Boyajian S, Ley K, Mazmanian SK. Bacterial colonization 
factors control specificity and stability of the gut microbiota. Nature. 2013; 501:426–429. 
[PubMed: 23955152] 
Fung et al. Page 14
Immunity. Author manuscript; available in PMC 2017 March 15.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Liu B, Tonkonogy SL, Sartor RB. Antigen-presenting cell production of IL-10 inhibits T-helper 1 and 
17 cell responses and suppresses colitis in mice. Gastroenterology. 2011; 141:653–662. 662.e651–
654. [PubMed: 21679711] 
Manichanh C, Borruel N, Casellas F, Guarner F. The gut microbiota in IBD. Nature reviews 
Gastroenterology & hepatology. 2012; 9:599–608. [PubMed: 22907164] 
Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis 
D, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor 
GPR43. Nature. 2009; 461:1282–1286. [PubMed: 19865172] 
McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, Cua DJ. TGF-
beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-
mediated pathology. Nature immunology. 2007; 8:1390–1397. [PubMed: 17994024] 
Obata T, Goto Y, Kunisawa J, Sato S, Sakamoto M, Setoyama H, Matsuki T, Nonaka K, Shibata N, 
Gohda M, et al. Indigenous opportunistic bacteria inhabit mammalian gut-associated lymphoid 
tissues and share a mucosal antibody-mediated symbiosis. Proceedings of the National Academy 
of Sciences of the United States of America. 2010; 107:7419–7424. [PubMed: 20360558] 
Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 
family of cytokines in inflammation and disease. Annual review of immunology. 2011; 29:71–109.
Qiu J, Guo X, Chen ZM, He L, Sonnenberg GF, Artis D, Fu YX, Zhou L. Group 3 innate lymphoid 
cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling 
and regulation of microflora. Immunity. 2013; 39:386–399. [PubMed: 23954130] 
Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal 
microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004; 118:229–241. 
[PubMed: 15260992] 
Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal 
bacterium of the intestinal microbiota. Proceedings of the National Academy of Sciences of the 
United States of America. 2010; 107:12204–12209. [PubMed: 20566854] 
Sander LE, Davis MJ, Boekschoten MV, Amsen D, Dascher CC, Ryffel B, Swanson JA, Muller M, 
Blander JM. Detection of prokaryotic mRNA signifies microbial viability and promotes immunity. 
Nature. 2011; 474:385–389. [PubMed: 21602824] 
Satoh-Takayama N, Vosshenrich CA, Lesjean-Pottier S, Sawa S, Lochner M, Rattis F, Mention JJ, 
Thiam K, Cerf-Bensussan N, Mandelboim O, et al. Microbial flora drives interleukin 22 
production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity. 
2008; 29:958–970. [PubMed: 19084435] 
Shih VF, Cox J, Kljavin NM, Dengler HS, Reichelt M, Kumar P, Rangell L, Kolls JK, Diehl L, Ouyang 
W, Ghilardi N. Homeostatic IL-23 receptor signaling limits Th17 response through IL-22-
mediated containment of commensal microbiota. Proceedings of the National Academy of 
Sciences of the United States of America. 2014; 111:13942–13947. [PubMed: 25201978] 
Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly YM, Glickman JN, Garrett WS. 
The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 
2013; 341:569–573. [PubMed: 23828891] 
Sonnenberg GF, Artis D. Innate lymphoid cells in the initiation, regulation and resolution of 
inflammation. Nat Med. 2015; 21:698–708. [PubMed: 26121198] 
Sonnenberg GF, Fouser LA, Artis D. Border patrol: regulation of immunity, inflammation and tissue 
homeostasis at barrier surfaces by IL-22. Nat Immunol. 2011; 12:383–390. [PubMed: 21502992] 
Sonnenberg GF, Monticelli LA, Alenghat T, Fung TC, Hutnick NA, Kunisawa J, Shibata N, Grunberg 
S, Sinha R, Zahm AM, et al. Innate lymphoid cells promote anatomical containment of lymphoid-
resident commensal bacteria. Science. 2012; 336:1321–1325. [PubMed: 22674331] 
Ueda Y, Kayama H, Jeon SG, Kusu T, Isaka Y, Rakugi H, Yamamoto M, Takeda K. Commensal 
microbiota induce LPS hyporesponsiveness in colonic macrophages via the production of IL-10. 
International immunology. 2010; 22:953–962. [PubMed: 21051439] 
Upadhyay V, Poroyko V, Kim TJ, Devkota S, Fu S, Liu D, Tumanov AV, Koroleva EP, Deng L, Nagler 
C, et al. Lymphotoxin regulates commensal responses to enable diet-induced obesity. Nature 
immunology. 2012; 13:947–953. [PubMed: 22922363] 
Fung et al. Page 15
Immunity. Author manuscript; available in PMC 2017 March 15.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Highlights
• Lymphoid-resident commensal bacteria (LRCs) colonize intestinal lymphoid 
tissues
• LRCs promote tissue-specific Th17 cell and ILC3 responses in intestinal tissues
• IL-22 enhances LRC colonization of intestinal lymphoid tissues
• LRCs provide host tissue protection during DSS in an IL-10R-dependent 
manner eTOC blurb
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Figure 1. Lymphoid tissue-resident commensal bacteria colonize bone marrow-derived and 
primary dendritic cells
(A) Maximum-likelihood tree of 47 bacterial genomes based on 40 universal single copy 
marker genes. Red symbols indicate published reference genomes. Blue symbols and text 
indicate in-house sequenced genomes. Scale bar indicates number of substitutions per site. 
(B) Bone marrow-derived dendritic cells (BMDCs) were co-cultured with representative 
LRCs or luminal-resident commensals and bacterial survival was measured at 0, 48 and 96 
hours. l.o.d., limit of detection. Data are representative of at least 2 independent 
experiments. (C) Primary DCs isolated from the mesenteric lymph node (mLN) of C57BL/6 
mice were co-cultured with the mouse-derived LRC, Bordetella spp. or luminal-resident 
commensal, E. coli ATCC 35328, and bacterial survival was measured at 0 and 96 hours. 
l.o.d., limit of detection. Data representative of 2 independent experiments (D) Bordetella-
colonized BMDCs were analyzed at day 5 post co-culture by transmission electron 
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microscopy. Images are representative of 10 individual bacteria-containing DCs. (E) 
Bordetella- and E. coli-colonized BMDCs were analyzed at day 0, 2 and 5 post-co-culture 
by immunofluorescence. Scale bar – 5 μm. Data representative of 2 independent 
experiments. (F) Percentage of BMDCs containing live (green) bacteria was quantified 
across 7–16 distinct fields of view. Infection efficiency (BMDCs containing live or dead 
bacteria/total BMDCs) on day 0 was approximately 15% for Bordetella spp. and 30% for E. 
coli. Data are represented as mean ± SEM. Statistics shown were performed using unpaired, 
two-tailed, student’s t test. ***, p < 0.0001. ND, not detectable. See also Figure S1 and 
Table S1.
Fung et al. Page 18
Immunity. Author manuscript; available in PMC 2017 March 15.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 2. Lymphoid tissue-resident commensal bacteria modulate cytokine responses in bone 
marrow-derived dendritic cells in a viability-dependent manner
(A) Genome-wide transcriptional profiling was performed on BMDCs co-cultured with live 
or heat-killed Bordetella spp. for 4 days. Numbers in colored legend represent Z scores. (B) 
BMDCs co-cultured with live or heat-killed Bordetella spp. for 24 hours were analyzed for 
cytokine gene expression by qPCR. (C) BMDCs co-cultured with live or heat-killed 
Bordetella spp. for 24 hours were analyzed for cytokine protein secretion by ELISA. qPCR 
and ELISA data were representative of at least 2 independent experiments. Data are 
represented as mean ± SEM. Statistics shown in B and C were performed using unpaired, 
two-tailed, student’s t test. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001. See 
also Figure S2.
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Figure 3. Colonization of intestinal-associated lymphoid tissues by lymphoid tissue-resident 
commensal bacteria modulates local Th17 cell responses
(A) Mesenteric lymph nodes (mLN) homogenates, (B) Peyer’s patches (PP) homogenates 
and (C) small intestinal lumen contents from GF and Bordetella spp. (LRC)-monocolonized 
mice were cultured determine bacterial CFUs. Data in (A) and (B) are representative of at 
least 2 independent experiments. (D) mLN, (E) PP and (F) small intestine lamina propria (SI 
LP) of conventionally-housed (CNV), GF, SFB-monocolonized and LRC-monocolonized 
mice were analyzed for frequencies of IL-17A+ and IFNγ+ CD4+ T cells by flow cytometry. 
(G) Frequencies of Th17 cells in CNV, GF, SFB-monocolonized and LRC-monocolonized 
mice. Values represent frequencies of IL-17A+ cells among CD4+ T cells. One-way 
ANOVA, mLN and SI LP - ****p < 0.0001; PP - **p < 0.01 (H and I) PPs of CNV, GF, 
SFB-monocolonized and LRC-monocolonized mice were analyzed for frequencies of IL-22-
producing Th17 cells by flow cytometry. Values represent frequencies of IL-22+ cells of 
IL-17A+ CD4+ T cells. One way ANOVA, mLN - ****p < 0.0001; PP - **p < 0.01; SI LP - 
*p < 0.05. Data are pooled from 2 independent experiments for a total of 6–8 mice per 
group. (J and K) Frequencies of Th17 cells (gated as CD3+CD4+RORγt+FOXP3−) in the 
mLN of LRC-monocolonized Il10+/+ or Il10−/− mice. Data representative of 2 independent 
experiments with 2–5 mice per group using Il10−/− monocolonized mice or C57BL/6 
monocolonized mice with anti-IL-10R treatment (500 μg/mouse i.p. every 3 days, analyzed 
on day 7). One-way ANOVA, ****p < 0.0001. Cells in all flow cytometry plots are gated as 
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live, CD3+ and CD4+. Data are represented as mean ± SEM. Statistics shown in panels G, I 
and K were performed using one-way ANOVA with unpaired, two-tailed, student’s t test 
with no correction for multiple comparisons. *, p < 0.05; **, p < 0.01; ***, p < 0.001. ND, 
not detectable. See also Figure S3.
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Figure 4. Colonization of intestinal-associated lymphoid tissues by lymphoid tissue-resident 
commensal bacteria promotes local ILC3 responses
(A) mLN, (B) PP and (C) SI LP of CNV, GF, SFB-monocolonized and Bordetella (LRC)-
monocolonized mice were analyzed for frequencies of ILC3 cells by flow cytometry. Cells 
in (A) were gated as live, lineage− (CD3−, CD5−, CD8α, CD11b−, B220−, NK1.1−). Cells in 
(B) and (C) were gated as live, CD45+ and lineage− . (D) Quantification of ILC3 frequencies 
in the mLN, PP and SI LP of CNV, GF, SFB-monocolonized and LRC-monocolonized mice. 
mLN ILC3 values represent frequencies of CD45+RORγt+ of lineage- cells. PP and SI LP 
ILC3 values represent frequencies of CD90+RORγt+ of lineage− cells. One-way ANOVA, 
mLN - ****p < 0.0001; PP - *p < 0.05; SI LP - **p < 0.01. (E) PPs of CNV, GF, SFB-
monocolonized and LRC-monocolonized mice were analyzed for frequencies of IL-22+ 
ILC3 cells by flow cytometry. Cells are gated as live, lineage−, CD90+ and RORγt+. Data are 
pooled from 2 independent experiments for a total of 6–8 mice per group. Data are 
represented as mean ± SEM. Statistics shown in panel D were performed using one-way 
ANOVA with uncorrected Fisher’s LSD test. *, p < 0.05; **, p < 0.01; ***, p < 0.001.
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Figure 5. Lymphoid tissue-resident commensal bacteria colonize antibiotic-treated mice and 
elicit innate immune responses that enhance colonization
Bacterial CFUs were determined in antibiotic (ABX)-treated control and ABX-resistant 
Achromobacter (LRCR)-colonized C57BL/6 PP and mLN homogenates (A and B) or 
Rag1−/− mLN homogenates (C). Data representative of at least 2 independent experiments. 
(D) LRCR 16S rDNA was measured in sorted CD11c+ cells from ABX-treated control or 
LRCR-colonized Rag1−/− mLN. (E) Expression of Il1b, Il10 and Il23a was measured in 
sorted CD11c+ cells from ABX-treated control or LRCR-colonized Rag1−/− mLN. Data 
pooled from 2 independent experiments for a total of 6 mice per group. (F) mLNs of CNV, 
ABX-treated and LRCR-colonized were analyzed for expression of Il17a and ll22. Data 
pooled from 2 independent experiments for a total of 6–8 mice per group. One-way 
ANOVA, Il17a – ****p < 0.0001; Il22 – **p < 0.01. (G and H) mLN and PP homogenates 
from LRCR-colonized C57BL6, Il17a−/− and Il22−/− mice were cultured to determine CFUs. 
(I) mLN homogenates from LRCR-colonized Rag1−/− and Rag1−/− Il22−/− mice were 
cultured to determine CFUs. Data pooled from 2 independent experiments for a total of 5–6 
mice per group. (J) mLN homogenates from control or recombinant mouse IL-22 (rIL-22)-
treated Rag1−/− mice were cultured to determine CFUs. Data representative of 2 independent 
experiments using recombinant mouse IL-22 or IL-22-Fc. (K and L) Whole PP and mLN 
were stained with Alcaligenes-specific 16S FISH probes ALBO (red) and BPA (green), and 
wheat germ agglutinin (blue). Data representative of 2 independent experiments with 2–5 
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mice per group. Number of puncta per mm3 of tissue was quantified. Data are represented as 
mean ± SEM. Statistics shown in panels E, F, J, K and L were performed using unpaired, 
two-tailed, student’s t test (E, J, K and L) and one-way ANOVA with uncorrected Fisher’s 
LSD test (F). *, p < 0.05; **, p < 0.01; ***, p < 0.001. ND, not detectable. See also Figure 
S4.
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Figure 6. Lymphoid tissue-resident commensal bacteria promote IL-10R-dependent protection 
from DSS-induced intestinal tissue damage and mortality
CNV, ABX-treated and ABX-resistant Achromobacter (LRCR)-colonized-colonized Rag1−/− 
mice were administered 2% DSS in their drinking water for 6 to 7 days and then placed on 
regular drinking water. Mice were monitored for survival (A) and weight loss (B) for up to 
21 days. Data in panel A are pooled from 2 independent experiments for a total of 8–9 mice 
per group. (C) Mice were sacrificed on day 6 and analyzed for colon tissue pathology and 
inflammatory infiltrate by H&E. Data in panel C are representative of 2 independent 
experiments. Scale bar – 100 μm. (D and E) ABX control, IgG- or anti-IL-10R-treated 
LRCR-colonized Rag1−/− mice were administered 2% DSS for 8 days. Percentage of starting 
weight on day 7 (D) and serum IFNγ on day 8 are quantified (E). One-way ANOVA, D and 
E - **p < 0.01. Data in panel D are pooled from 3 independent experiments for a total of 12–
13 mice per group. Data in panel E are pooled from 3 independent experiments for a total of 
8–12 mice per group. Data are represented as mean ± SEM. Statistics shown in B were 
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performed using unpaired, two-tailed, student’s t test. Statistics shown in panels D and E 
were performed using one-way ANOVA with uncorrected Fisher’s LSD test. *, p < 0.05; **, 
p < 0.01; ***, p < 0.001. See also Figures S5 and S6.
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